A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults. PLoS One, 7, e41936. presented at the 08/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22870265. (2012).
A Cross-Sectional Study in Eastern and Southern Africa to Characterize Laboratory Reference Intervals in Healthy Adults for HIV Prevention Trials. In AIDS Vaccine 2008 Conference. presented at the 13/10/2008, Cape Town, South Africa. Retrieved from http://www.vaccineenterprise.org/conference_archive/2008/index.html. (2008).
A Phase I Study to Evaluate the Safety and Immunogenicity of a Recombinant Modified Vaccinia Ankara Virus (TBC-M4) Multigenic HIV Subtype C Vaccine. In AIDS Vaccine 2007 Conference. presented at the 20/08/2007, Seattle, WA. Retrieved from http://www.vaccineenterprise.org/conference_archive/2007/index.html. (2007).